Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Survival differences by race/ethnicity among children and adolescents diagnosed with germ cell tumors.

Williams LA, Frazier AL, Poynter JN.

Int J Cancer. 2019 Jul 15. doi: 10.1002/ijc.32569. [Epub ahead of print]

PMID:
31304572
2.

Global childhood cancer survival estimates and priority-setting: a simulation-based analysis.

Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Girardi F, Atun R.

Lancet Oncol. 2019 Jul;20(7):972-983. doi: 10.1016/S1470-2045(19)30273-6. Epub 2019 May 22.

PMID:
31129029
3.

Identification of testicular cancer driver genes by a cross-species comparative oncology approach.

Sanchez A, Xu L, Pierce JL, Lafin JT, Abe D, Bagrodia A, Frazier AL, Amatruda JF.

Andrology. 2019 May 13. doi: 10.1111/andr.12644. [Epub ahead of print]

PMID:
31087453
4.

Reply to Letter to the Editor "Staging of acute leukemia based on central nervous system involvement alone: Is it appropriate?"

Gupta S, Frazier AL, Aitken JF.

Pediatr Blood Cancer. 2019 Aug;66(8):e27756. doi: 10.1002/pbc.27756. Epub 2019 Apr 23. No abstract available.

PMID:
31012523
5.

Multicenter pre-operative assessment of pediatric ovarian malignancy.

Madenci AL, Vandewalle RJ, Dieffenbach BV, Laufer MR, Boyd TK, Voss SD, Frazier AL, Billmire DF, Rescorla FJ, Weil BR, Weldon CB.

J Pediatr Surg. 2019 Feb 25. pii: S0022-3468(19)30136-8. doi: 10.1016/j.jpedsurg.2019.02.019. [Epub ahead of print]

PMID:
30867096
6.

Stage at diagnosis for childhood solid cancers in Australia: A population-based study.

Youlden DR, Frazier AL, Gupta S, Pritchard-Jones K, Kirby ML, Baade PD, Green AC, Valery PC, Aitken JF.

Cancer Epidemiol. 2019 Apr;59:208-214. doi: 10.1016/j.canep.2019.02.013. Epub 2019 Mar 1.

7.

DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies-Response.

Bauer AJ, Stewart DR, Kamihara J, Harris AK, Turner J, Shah R, Schneider KW, Schneider K, Carr AG, Harney LA, Frazier AL, Orbach D, Schneider DT, Malkin D, Dehner LP, Messinger YH, Hill DA, Schultz KAP.

Clin Cancer Res. 2019 Mar 1;25(5):1689-1690. doi: 10.1158/1078-0432.CCR-18-3495. No abstract available.

PMID:
30824630
8.

Estimating the total incidence of global childhood cancer: a simulation-based analysis.

Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Atun R.

Lancet Oncol. 2019 Apr;20(4):483-493. doi: 10.1016/S1470-2045(18)30909-4. Epub 2019 Feb 26.

PMID:
30824204
9.

Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry.

Youlden DR, Gupta S, Frazier AL, Moore AS, Baade PD, Valery PC, Green AC, Aitken JF.

Pediatr Blood Cancer. 2019 Jun;66(6):e27683. doi: 10.1002/pbc.27683. Epub 2019 Feb 25.

PMID:
30803139
10.

Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function.

Adamson PC, Veal GJ, Womer RB, Meany HJ, Bernhardt MB, Frazier AL, Balis FM.

Pediatr Blood Cancer. 2019 Jun;66(6):e27672. doi: 10.1002/pbc.27672. Epub 2019 Feb 15.

PMID:
30767382
11.

Nutritional status and clinical outcomes in pediatric patients with solid tumors : A systematic review of the literature.

Joffe L, Dwyer S, Glade Bender JL, Frazier AL, Ladas EJ.

Semin Oncol. 2019 Feb;46(1):48-56. doi: 10.1053/j.seminoncol.2018.11.005. Epub 2018 Dec 21.

PMID:
30655021
12.

Sense of Mission and Subsequent Health and Well-Being Among Young Adults: An Outcome-Wide Analysis.

Chen Y, Kim ES, Koh HK, Frazier AL, VanderWeele TJ.

Am J Epidemiol. 2019 Apr 1;188(4):664-673. doi: 10.1093/aje/kwz009.

13.

Childhood cancer burden: a review of global estimates.

Bhakta N, Force LM, Allemani C, Atun R, Bray F, Coleman MP, Steliarova-Foucher E, Frazier AL, Robison LL, Rodriguez-Galindo C, Fitzmaurice C.

Lancet Oncol. 2019 Jan;20(1):e42-e53. doi: 10.1016/S1470-2045(18)30761-7. Review.

PMID:
30614477
14.

Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

Fonseca A, Xia C, Lorenzo AJ, Krailo M, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Billmire DF, Rodriguez-Galindo C, Frazier AL, Shaikh F.

J Clin Oncol. 2019 Feb 10;37(5):396-402. doi: 10.1200/JCO.18.00790. Epub 2018 Dec 21.

15.

Klinefelter syndrome in males with germ cell tumors: A report from the Children's Oncology Group.

Williams LA, Pankratz N, Lane J, Krailo M, Roesler M, Richardson M, Frazier AL, Amatruda JF, Poynter JN.

Cancer. 2018 Oct 1;124(19):3900-3908. doi: 10.1002/cncr.31667. Epub 2018 Oct 6.

PMID:
30291793
16.

Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group.

Williams LA, Mills L, Hooten AJ, Langer E, Roesler M, Frazier AL, Krailo M, Nelson HH, Bestrashniy J, Amatruda JF, Poynter JN.

Br J Cancer. 2018 Oct;119(7):864-872. doi: 10.1038/s41416-018-0277-5. Epub 2018 Oct 5.

PMID:
30287918
17.

Pediatric vincristine-related vocal fold paralysis.

Hseu A, Ayele N, Kawai K, Frazier AL, Mack J, Watters K, Nuss R, Rahbar R.

Int J Pediatr Otorhinolaryngol. 2018 Nov;114:166-169. doi: 10.1016/j.ijporl.2018.08.017. Epub 2018 Sep 11. No abstract available.

PMID:
30262358
18.

Sodium Thiosulfate and Cisplatin-Induced Hearing Loss.

Freyer DR, Frazier AL, Sung L.

N Engl J Med. 2018 Sep 20;379(12):1180-1. doi: 10.1056/NEJMc1809501. No abstract available.

PMID:
30260148
19.

Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study.

Aitken JF, Youlden DR, Moore AS, Baade PD, Ward LJ, Thursfield VJ, Valery PC, Green AC, Gupta S, Frazier AL.

Lancet Child Adolesc Health. 2018 Mar;2(3):173-179. doi: 10.1016/S2352-4642(18)30023-3. Epub 2018 Feb 1.

PMID:
30169253
20.

Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?

Shah R, Xia C, Krailo M, Amatruda JF, Arul SG, Billmire DF, Brady WE, Covens A, Gershenson DM, Hale JP, Hurteau J, Murray MJ, Nicholson JC, Olson TA, Pashankar F, Rodriguez-Galindo C, Shaikh F, Stark D, Frazier AL, Stoneham S.

Gynecol Oncol. 2018 Aug;150(2):253-260. doi: 10.1016/j.ygyno.2018.05.025. Epub 2018 Jun 5.

21.

Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium.

Frazier AL, Stoneham S, Rodriguez-Galindo C, Dang H, Xia C, Olson TA, Murray MJ, Amatruda JF, Shaikh F, Pashankar F, Billmire D, Krailo M, Stark D, Brougham MFH, Nicholson JC, Hale JP.

Eur J Cancer. 2018 Jul;98:30-37. doi: 10.1016/j.ejca.2018.03.004. Epub 2018 May 31.

22.

Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials.

Minasian LM, Frazier AL, Sung L, O'Mara A, Kelaghan J, Chang KW, Krailo M, Pollock BH, Reaman G, Freyer DR.

Cancer Med. 2018 May 30. doi: 10.1002/cam4.1563. [Epub ahead of print]

23.

Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study.

Pashankar F, Frazier AL, Krailo M, Xia C, Pappo AS, Malogolowkin M, Olson TA, Rodriguez-Galindo C.

Pediatr Blood Cancer. 2018 Aug;65(8):e27111. doi: 10.1002/pbc.27111. Epub 2018 Apr 26.

PMID:
29697191
24.

Pediatric Germ Cell Tumors: A Developmental Perspective.

Pierce JL, Frazier AL, Amatruda JF.

Adv Urol. 2018 Feb 4;2018:9059382. doi: 10.1155/2018/9059382. eCollection 2018. Review.

25.

EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.

Chen KS, Fustino NJ, Shukla AA, Stroup EK, Budhipramono A, Ateek C, Stuart SH, Yamaguchi K, Kapur P, Frazier AL, Lum L, Looijenga LHJ, Laetsch TW, Rakheja D, Amatruda JF.

Mol Cancer Ther. 2018 May;17(5):1079-1089. doi: 10.1158/1535-7163.MCT-17-0137. Epub 2018 Feb 26.

26.

Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors.

Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL.

Oncologist. 2018 Feb;23(2):272. doi: 10.1634/theoncologist.2014-0009erratum. No abstract available.

27.

DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies.

Schultz KAP, Williams GM, Kamihara J, Stewart DR, Harris AK, Bauer AJ, Turner J, Shah R, Schneider K, Schneider KW, Carr AG, Harney LA, Baldinger S, Frazier AL, Orbach D, Schneider DT, Malkin D, Dehner LP, Messinger YH, Hill DA.

Clin Cancer Res. 2018 May 15;24(10):2251-2261. doi: 10.1158/1078-0432.CCR-17-3089. Epub 2018 Jan 17. Review.

28.

Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Coccia PF, Pappo AS, Beaupin L, Borges VF, Borinstein SC, Chugh R, Dinner S, Folbrecht J, Frazier AL, Goldsby R, Gubin A, Hayashi R, Huang MS, Link MP, Livingston JA, Matloub Y, Millard F, Oeffinger KC, Puccetti D, Reed D, Robinson S, Rosenberg AR, Sanft T, Spraker-Perlman HL, von Mehren M, Wechsler DS, Whelan KF, Yeager N, Gurski LA, Shead DA.

J Natl Compr Canc Netw. 2018 Jan;16(1):66-97. doi: 10.6004/jnccn.2018.0001.

PMID:
29295883
29.

Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study.

Dicken BJ, Billmire DF, Krailo M, Xia C, Shaikh F, Cullen JW, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Rescorla FJ, Egler RA, Ross JH, Rodriguez-Galindo C, Frazier AL.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26913. Epub 2017 Dec 29.

30.

AALAS Publications: Write for All Readers.

Frazier AL.

J Am Assoc Lab Anim Sci. 2017 Nov 1;56(6):710. No abstract available.

31.

AALAS Publications: Write for All Readers.

Frazier AL.

Comp Med. 2017 Dec 1;67(6):468. No abstract available.

32.

Future cancer research priorities in the USA: a Lancet Oncology Commission.

Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A.

Lancet Oncol. 2017 Nov;18(11):e653-e706. doi: 10.1016/S1470-2045(17)30698-8. Epub 2017 Oct 31. Review.

33.

Ovarian Yolk Sac Tumors; Does Age Matter?

Faure Conter C, Xia C, Gershenson D, Hurteau J, Covens A, Pashankar F, Krailo M, Billmire D, Patte C, Fresneau B, Shaikh F, Stoneham S, Nicholson J, Murray M, Frazier AL.

Int J Gynecol Cancer. 2018 Jan;28(1):77-84. doi: 10.1097/IGC.0000000000001149. Erratum in: Int J Gynecol Cancer. 2018 May;28(4):851.

PMID:
29194189
34.

Family history of cancer in children and adolescents with germ cell tumours: a report from the Children's Oncology Group.

Poynter JN, Richardson M, Roesler M, Krailo M, Amatruda JF, Frazier AL.

Br J Cancer. 2018 Jan;118(1):121-126. doi: 10.1038/bjc.2017.358. Epub 2017 Oct 24.

35.

DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.

Schultz KAP, Harris AK, Finch M, Dehner LP, Brown JB, Gershenson DM, Young RH, Field A, Yu W, Turner J, Cost NG, Schneider DT, Stewart DR, Frazier AL, Messinger Y, Hill DA.

Gynecol Oncol. 2017 Dec;147(3):521-527. doi: 10.1016/j.ygyno.2017.09.034. Epub 2017 Oct 14.

36.

Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma.

Gauguet JM, Pace-Emerson T, Grant FD, Shusterman S, DuBois SG, Frazier AL, Voss SD.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26601. Epub 2017 Apr 27.

PMID:
28449267
37.

The global burden of childhood cancer: Knowing what we do not know.

Frazier AL, PiƱeros M, Fuentes S, Bhakta N.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26532. Epub 2017 Apr 14. No abstract available.

PMID:
28409882
38.

Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group.

Marcotte EL, Pankratz N, Amatruda JF, Frazier AL, Krailo M, Davies S, Starr JR, Lau CC, Roesler M, Langer E, Hallstrom C, Hooten AJ, Poynter JN.

Genes Chromosomes Cancer. 2017 Jul;56(7):548-558. doi: 10.1002/gcc.22457. Epub 2017 Apr 4.

39.

Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

Shaikh F, Cullen JW, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Villaluna D, Krailo M, Billmire DF, Rescorla FJ, Egler RA, Dicken BJ, Ross JH, Schlatter M, Rodriguez-Galindo C, Frazier AL.

J Clin Oncol. 2017 Apr 10;35(11):1203-1210. doi: 10.1200/JCO.2016.67.6544. Epub 2017 Feb 27.

40.

Body size from birth through adolescence in relation to risk of benign breast disease in young women.

Berkey CS, Rosner B, Tamimi RM, Willett WC, Hickey M, Toriola A, Frazier AL, Colditz GA.

Breast Cancer Res Treat. 2017 Feb;162(1):139-149. doi: 10.1007/s10549-016-4084-5. Epub 2017 Jan 6.

41.

Risk of second malignant neoplasms in women and girls with germ cell tumors.

Liao Z, Rodrigues MC, Poynter JN, Amatruda JF, Rodriguez-Galindo C, Frazier AL.

Ann Oncol. 2017 Feb 1;28(2):329-332. doi: 10.1093/annonc/mdw609.

PMID:
27864217
42.

Ovarian Sex Cord-Stromal Tumors.

Schultz KA, Harris AK, Schneider DT, Young RH, Brown J, Gershenson DM, Dehner LP, Hill DA, Messinger YH, Frazier AL.

J Oncol Pract. 2016 Oct;12(10):940-946.

43.

Patient-Reported Measures of Hearing Loss and Tinnitus in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.

Stark D, Rosenberg AR, Johnston D, Knight K, Caperon L, Uleryk E, Frazier AL, Sung L.

J Speech Lang Hear Res. 2016 Oct 1;59(5):1247-1252. doi: 10.1044/2016_JSLHR-H-15-0363. Review.

44.

Is surgical resection and observation sufficient for stage I and II sacrococcygeal germ cell tumors? A case series and review.

Egler RA, Gosiengfiao Y, Russell H, Wickiser JE, Frazier AL.

Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26311. Epub 2016 Oct 27. Review.

PMID:
27786428
45.

Conundrums in the management of malignant ovarian germ cell tumors: Toward lessening acute morbidity and late effects of treatment.

Gershenson DM, Frazier AL.

Gynecol Oncol. 2016 Nov;143(2):428-432. doi: 10.1016/j.ygyno.2016.08.329. Epub 2016 Aug 25. Review.

PMID:
27569583
46.

Socioeconomic status and global variations in the incidence of neuroblastoma: call for support of population-based cancer registries in low-middle-income countries.

Kamihara J, Ma C, Fuentes Alabi SL, Garrido C, Frazier AL, Rodriguez-Galindo C, Orjuela MA.

Pediatr Blood Cancer. 2017 Feb;64(2):321-323. doi: 10.1002/pbc.26244. Epub 2016 Oct 13.

47.

Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines.

Gupta S, Aitken JF, Bartels U, Brierley J, Dolendo M, Friedrich P, Fuentes-Alabi S, Garrido CP, Gatta G, Gospodarowicz M, Gross T, Howard SC, Molyneux E, Moreno F, Pole JD, Pritchard-Jones K, Ramirez O, Ries LAG, Rodriguez-Galindo C, Shin HY, Steliarova-Foucher E, Sung L, Supriyadi E, Swaminathan R, Torode J, Vora T, Kutluk T, Frazier AL.

Lancet Oncol. 2016 Apr;17(4):e163-e172. doi: 10.1016/S1470-2045(15)00539-2. Epub 2016 Mar 29. Review.

PMID:
27300676
48.

Paediatric extracranial germ-cell tumours.

Shaikh F, Murray MJ, Amatruda JF, Coleman N, Nicholson JC, Hale JP, Pashankar F, Stoneham SJ, Poynter JN, Olson TA, Billmire DF, Stark D, Rodriguez-Galindo C, Frazier AL.

Lancet Oncol. 2016 Apr;17(4):e149-e162. doi: 10.1016/S1470-2045(15)00545-8. Epub 2016 Mar 29. Review. Erratum in: Lancet Oncol. 2018 Feb;19(2):e78.

49.

Preoperative risk stratification of children with ovarian tumors.

Madenci AL, Levine BS, Laufer MR, Boyd TK, Voss SD, Zurakowski D, Frazier AL, Weldon CB.

J Pediatr Surg. 2016 Sep;51(9):1507-12. doi: 10.1016/j.jpedsurg.2016.05.004. Epub 2016 May 31.

PMID:
27289417
50.

Can Big Data Shed Light on the Origins of Pediatric Cancer?

Frazier AL, Krailo M, Poynter J.

Pediatrics. 2016 Jun;137(6). pii: e20160983. doi: 10.1542/peds.2016-0983. No abstract available.

Supplemental Content

Loading ...
Support Center